USD 0.22
(3.19%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 18.12 Million USD | -16.51% |
2022 | 21.71 Million USD | 36.71% |
2021 | 15.88 Million USD | 114.33% |
2020 | 7.4 Million USD | 77.27% |
2019 | 4.17 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 1.74 Million USD | -20.31% |
2024 Q1 | 2.18 Million USD | -66.63% |
2023 FY | 18.12 Million USD | -16.51% |
2023 Q3 | 3.23 Million USD | -8.78% |
2023 Q4 | 6.55 Million USD | 102.72% |
2023 Q2 | 3.54 Million USD | -26.24% |
2023 Q1 | 4.8 Million USD | -26.97% |
2022 Q3 | 5.67 Million USD | 23.58% |
2022 Q2 | 4.59 Million USD | -5.67% |
2022 Q1 | 4.86 Million USD | -13.22% |
2022 FY | 21.71 Million USD | 36.71% |
2022 Q4 | 6.57 Million USD | 15.86% |
2021 Q1 | 2.89 Million USD | 51.91% |
2021 FY | 15.88 Million USD | 114.33% |
2021 Q4 | 5.6 Million USD | 24.73% |
2021 Q3 | 4.49 Million USD | 56.27% |
2021 Q2 | 2.87 Million USD | -0.63% |
2020 Q3 | 1.81 Million USD | -2.97% |
2020 Q2 | 1.86 Million USD | 2.17% |
2020 FY | 7.4 Million USD | 77.27% |
2020 Q1 | 1.82 Million USD | 0.0% |
2020 Q4 | 1.9 Million USD | 5.29% |
2019 FY | 4.17 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Ontrak, Inc. | 29.47 Million USD | 38.507% |
iCoreConnect Inc. | 15.12 Million USD | -19.842% |
Augmedix, Inc. | 40.3 Million USD | 55.03% |
BrightSpring Health Services, Inc. Common Stock | 1.28 Billion USD | 98.591% |
CareCloud, Inc. | 93.35 Million USD | 80.585% |
CareCloud, Inc. | 93.35 Million USD | 80.585% |
HealthEquity, Inc. | 401.74 Million USD | 95.488% |
Inovalon Holdings, Inc. | 427.99 Million USD | 95.765% |
Nutex Health, Inc. | 66.54 Million USD | 72.764% |
OneMedNet Corporation | 8.24 Million USD | -119.794% |
Progyny, Inc. | 176.61 Million USD | 89.738% |
Omnicell, Inc. | 534.79 Million USD | 96.611% |
Renalytix Plc | 29.04 Million USD | 37.588% |
Schrödinger, Inc. | 318.14 Million USD | 94.303% |
Simulations Plus, Inc. | 37.02 Million USD | 51.04% |
SOPHiA GENETICS SA | 117.73 Million USD | 84.606% |
Streamline Health Solutions, Inc. | 31.19 Million USD | 41.888% |
Minerva Surgical, Inc. | 58.14 Million USD | 68.826% |
GE HealthCare Technologies Inc. | 5.48 Billion USD | 99.67% |
Sharecare, Inc. | 225.97 Million USD | 91.979% |
Aclarion, Inc. | 4.87 Million USD | -271.745% |
CareMax, Inc. | 670.05 Million USD | 97.295% |
Bullfrog AI Holdings, Inc. Common Stock | 5.42 Million USD | -233.958% |
Forian Inc. | 20.59 Million USD | 12.012% |
Bullfrog AI Holdings, Inc. Warrants | 5.42 Million USD | -233.958% |
HeartBeam, Inc. | 15.31 Million USD | -18.356% |
GeneDx Holdings Corp. | 224.28 Million USD | 91.919% |
SCWorx Corp. | 2.71 Million USD | -566.424% |
Definitive Healthcare Corp. | 546.47 Million USD | 96.683% |
10x Genomics, Inc. | 674.94 Million USD | 97.315% |
Zhongchao Inc. | 13.92 Million USD | -30.185% |
Accolade, Inc. | 306.51 Million USD | 94.087% |
MSP Recovery, Inc. | 565.43 Million USD | 96.794% |
R1 RCM Inc. | 336.6 Million USD | 94.615% |
Spok Holdings, Inc. | 90.97 Million USD | 80.078% |
Privia Health Group, Inc. | 134.31 Million USD | 86.506% |
EUDA Health Holdings Limited | 4.8 Million USD | -277.358% |
TruBridge, Inc. | 206.17 Million USD | 91.209% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 1.28 Billion USD | 98.591% |
Sharecare, Inc. | 225.97 Million USD | 91.979% |
Health Catalyst, Inc. | 258.73 Million USD | 92.995% |
GoodRx Holdings, Inc. | 710.34 Million USD | 97.448% |
Premier, Inc. | 683.65 Million USD | 97.349% |
HealthStream, Inc. | 168.02 Million USD | 89.213% |
Certara, Inc. | 254.08 Million USD | 92.867% |
GeneDx Holdings Corp. | 224.28 Million USD | 91.919% |
Ontrak, Inc. | 29.47 Million USD | 38.507% |
SHL Telemedicine Ltd. | 34.26 Million USD | 47.107% |
CareCloud, Inc. | 93.35 Million USD | 80.585% |
EUDA Health Holdings Limited | 4.8 Million USD | -277.358% |
HeartBeam, Inc. | 15.31 Million USD | -18.356% |
Mangoceuticals, Inc. | 9.65 Million USD | -87.816% |
CareMax, Inc. | 670.05 Million USD | 97.295% |
National Research Corporation | 52.52 Million USD | 65.489% |
Aclarion, Inc. | 4.87 Million USD | -271.745% |
OptimizeRx Corporation | 69.3 Million USD | 73.846% |